Mina Fouad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mina Fouad has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Abed Moeti Zaitoun
Department of Cellular Pathology, Nottingham University Hospitals NHS Trust, Queen’s Medical Centre , Derby Road, Nottingham NG7 2UH , Nottinghamshire
3 shared publications Peter Ibraheim
Department of Diagnostic Radiology, Banha University, Banha, Egypt
2 shared publications- Prithvirao Sonoo
Department of Hepatobiliary and Pancreatic Surgery, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
2 shared publications - Sandy M. N. Ibraheim
Cairo University Teaching Hospital Cairo Egypt
2 shared publications - Sayed Ali Almahari
Department of Cellular Pathology, Nottingham University Hospitals NHS Trust, Queen’s Medical Centre , Derby Road, Nottingham NG7 2UH, Nottinghamshire
2 shared publications Ahmed Khalifa
Cairo University Teaching Hospital Cairo Egypt
1 shared publication
Latest Publications
- 12 November 2026
- Published by Wiley in World Journal of Surgery
Pancreatic Exocrine Insufficiency Following Esophagectomy, Gastrectomy and Bariatric Surgery: A Systematic Review and Narrative Synthesis
Background: Pancreatic exocrine insufficiency (PEI) is an increasingly recognised consequence of esophagogastric surgery; however, its prevalence, burden across different surgical procedures, and optimal approaches to diagnosis and management remain incompletely characterized. This review aims to systematically evaluate the prevalence, diagnosis, clinical manifestations, nutritional consequences and management of PEI following esophagogastric surgery in adults. Methods: A systematic review and meta‐analysis was conducted according to Joanna Briggs Institute methodology and reported in accordance with PRISMA 2020. PubMed, Scopus, Web of Science and Embase were searched from January 2011 to May 2026. Eligible studies reported PEI following esophagectomy, gastrectomy, or bariatric surgery. Owing to substantial clinical and methodological heterogeneity, findings were synthesized narratively by surgical group and procedure. Risk of bias was evaluated using JBI critical appraisal tools. Results: Seventeen studies comprising 1397 patients were included. Reported PEI prevalence varied substantially across surgical populations, ranging from 3.2% to 22.0% following esophagectomy, 25.0%–63.8% following gastrectomy, and 9.1%–32.6% in bariatric cohorts. Procedure‐specific estimates varied considerably, with rates of 4.2%–17.2% following sleeve gastrectomy, 8.3%–10.3% following RYGB, 48.1% following distal RYGB and 75.0% following biliopancreatic diversion with duodenal switch. Fecal elastase‐1 was the most frequently used diagnostic test, although diagnostic criteria and timing of assessment varied between studies. Gastrointestinal symptoms, weight loss, nutritional deficiencies and impaired quality of life were reported, while limited observational evidence suggested symptomatic improvement following pancreatic enzyme replacement therapy. Conclusions: PEI is an under‐recognised consequence of esophagectomy, gastrectomy and bariatric surgery, with reported prevalence varying substantially between procedures and studies. Greater clinical awareness and standardised approaches to diagnosis are required, alongside prospective studies to better define postoperative screening and management. Trial Registration: This review was prospectively registered in PROSPERO (CRD420261369499)
- 12 November 2026
- Published by Wiley in World Journal of Surgery
Pancreatic Exocrine Insufficiency Following Esophagectomy, Gastrectomy and Bariatric Surgery: A Systematic Review and Narrative Synthesis
Background: Pancreatic exocrine insufficiency (PEI) is an increasingly recognised consequence of esophagogastric surgery; however, its prevalence, burden across different surgical procedures, and optimal approaches to diagnosis and management remain incompletely characterized. This review aims to systematically evaluate the prevalence, diagnosis, clinical manifestations, nutritional consequences and management of PEI following esophagogastric surgery in adults. Methods: A systematic review and meta‐analysis was conducted according to Joanna Briggs Institute methodology and reported in accordance with PRISMA 2020. PubMed, Scopus, Web of Science and Embase were searched from January 2011 to May 2026. Eligible studies reported PEI following esophagectomy, gastrectomy, or bariatric surgery. Owing to substantial clinical and methodological heterogeneity, findings were synthesized narratively by surgical group and procedure. Risk of bias was evaluated using JBI critical appraisal tools. Results: Seventeen studies comprising 1397 patients were included. Reported PEI prevalence varied substantially across surgical populations, ranging from 3.2% to 22.0% following esophagectomy, 25.0%–63.8% following gastrectomy, and 9.1%–32.6% in bariatric cohorts. Procedure‐specific estimates varied considerably, with rates of 4.2%–17.2% following sleeve gastrectomy, 8.3%–10.3% following RYGB, 48.1% following distal RYGB and 75.0% following biliopancreatic diversion with duodenal switch. Fecal elastase‐1 was the most frequently used diagnostic test, although diagnostic criteria and timing of assessment varied between studies. Gastrointestinal symptoms, weight loss, nutritional deficiencies and impaired quality of life were reported, while limited observational evidence suggested symptomatic improvement following pancreatic enzyme replacement therapy. Conclusions: PEI is an under‐recognised consequence of esophagectomy, gastrectomy and bariatric surgery, with reported prevalence varying substantially between procedures and studies. Greater clinical awareness and standardised approaches to diagnosis are required, alongside prospective studies to better define postoperative screening and management. Trial Registration: This review was prospectively registered in PROSPERO (CRD420261369499)
- Open Access
- 18 February 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (2)
Multiple small intestinal metastatic tumours: from basics to advanced testing
We report the case of a patient with 13 metastatic small bowel tumours presenting with upper gastrointestinal bleeding. He had a video-assisted thoracoscopic left upper lobectomy a year previously for a lung adenocarcinoma. Histological findings of the resected small bowel confirmed a poorly differentiated anaplastic adenocarcinoma (pT3 N1 Mx). Molecular testing on the tumour showed that it harboured KRAS c.182A > T (p.Gln61Leu) mutation, which was similar to the mutation reported on the primary lung adenocarcinoma. Based on this he received adjuvant chemotherapy and immunotherapy (carboplatin, pemetrexed and pembrolizumab) and a CT scan performed two months after the small bowel resection demonstrated no evidence of tumour recurrence. He, however, developed chemotherapy-related nausea and vomiting, and with further deterioration was placed on a palliative care pathway and died 3 months after the bowel resection. This case highlights the role of integrating histopathology, immunohistochemistry, and molecular genetics in distinguishing metastatic from primary small intestinal adenocarcinomas.
- 18 February 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (2)
Open AccessMultiple small intestinal metastatic tumours: from basics to advanced testing
We report the case of a patient with 13 metastatic small bowel tumours presenting with upper gastrointestinal bleeding. He had a video-assisted thoracoscopic left upper lobectomy a year previously for a lung adenocarcinoma. Histological findings of the resected small bowel confirmed a poorly differentiated anaplastic adenocarcinoma (pT3 N1 Mx). Molecular testing on the tumour showed that it harboured KRAS c.182A > T (p.Gln61Leu) mutation, which was similar to the mutation reported on the primary lung adenocarcinoma. Based on this he received adjuvant chemotherapy and immunotherapy (carboplatin, pemetrexed and pembrolizumab) and a CT scan performed two months after the small bowel resection demonstrated no evidence of tumour recurrence. He, however, developed chemotherapy-related nausea and vomiting, and with further deterioration was placed on a palliative care pathway and died 3 months after the bowel resection. This case highlights the role of integrating histopathology, immunohistochemistry, and molecular genetics in distinguishing metastatic from primary small intestinal adenocarcinomas.
- Open Access
- 1 January 2026
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 108 (1) , 72-75
Recurrent ascending cholangitis secondary to food reflux following transduodenal resection of an ampullary adenoma
Ampullary lesions, including adenomas and early-stage carcinomas, pose a diagnostic and therapeutic challenge because of their location and proximity to the pancreatic and bile ducts. Transduodenal ampullectomy offers a targeted approach for the resection of these lesions while preserving the integrity of the pancreaticobiliary system. Moreover, transduodenal ampullectomy is associated with favourable postoperative outcomes, including low rates of morbidity and mortality, as well as preservation of pancreatic and biliary function. However, potential complications such as ascending cholangitis pancreatic leakage, bleeding and duodenal stenosis can occur, which would impact the postoperative quality of life. Addressing these outcomes might require either endoscopic procedures or surgical interventions. We present an exceedingly uncommon case of recurrent ascending cholangitis resulting from reflux of food particles into the common bile duct that was treated successfully with a Roux-en-Y hepaticojejunostomy and gastroenterostomy.
- 1 January 2026
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 108 (1) , 72-75
Open AccessRecurrent ascending cholangitis secondary to food reflux following transduodenal resection of an ampullary adenoma
Ampullary lesions, including adenomas and early-stage carcinomas, pose a diagnostic and therapeutic challenge because of their location and proximity to the pancreatic and bile ducts. Transduodenal ampullectomy offers a targeted approach for the resection of these lesions while preserving the integrity of the pancreaticobiliary system. Moreover, transduodenal ampullectomy is associated with favourable postoperative outcomes, including low rates of morbidity and mortality, as well as preservation of pancreatic and biliary function. However, potential complications such as ascending cholangitis pancreatic leakage, bleeding and duodenal stenosis can occur, which would impact the postoperative quality of life. Addressing these outcomes might require either endoscopic procedures or surgical interventions. We present an exceedingly uncommon case of recurrent ascending cholangitis resulting from reflux of food particles into the common bile duct that was treated successfully with a Roux-en-Y hepaticojejunostomy and gastroenterostomy.
- 14 December 2025
- Published by Elsevier in Pancreatology
- Vol. 26 (1) , 58-64
Gallstone Pancreatitis: Clinical outcomes and economic impact at a tertiary UK Hepatobiliary centre
- 14 December 2025
- Published by Elsevier in Pancreatology
- Vol. 26 (1) , 58-64
Gallstone Pancreatitis: Clinical outcomes and economic impact at a tertiary UK Hepatobiliary centre
- Open Access
- 30 October 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (11) , 202
Outcomes Following Surgery for Pancreatic Neuro-Endocrine Tumours: A Single-Centre Experience
Aims: The purpose of this study was to evaluate survival outcomes and recurrence patterns following curative-intent resection of pancreatic neuroendocrine tumours (PNETs) at a UK tertiary centre. The secondary aims included identifying prognostic clinicopathological factors that influenced survival. Methods: Patients undergoing curative-intent surgical resection for PNETs between August 2010 and March 2024 were retrospectively reviewed. The data collated included demographics, histopathology, recurrence, and survival outcomes. Results: Eighty-six patients were included, with a median age of 61.5 years (IQR: 50–71) and an equal sex distribution. Most tumours were solitary (88.4%) and located in the pancreatic tail (57%), with distal pancreatectomy performed in 75% of cases. The median tumour size was 25 mm (IQR: 13–40). Lymph node metastases were observed in 23.3% of patients, and R0 resection was achieved in 67%. Most of the PNETs resected were WHO grade 1 tumours (65.1%), followed by grade 2 tumours (26.7%). Postoperative morbidity occurred in 37.2% of cases, while the 30-day postoperative mortality rate was 1.5%. Recurrence was observed in 13.95% of patients, with a median time to recurrence of 36.3 months. The 5-year overall survival (OS) was 83.0%, with a median OS and disease-free survival (DFS) of 143.3 months and 147.0 months, respectively. Multivariable analysis revealed that poorer DFS was associated with larger tumours (p = 0.009), higher tumour grade (p = 0.006), male sex (p = 0.039), vascular invasion (p = 0.003), perineural invasion (p = 0.042) and lymph node metastases (p = 0.015). OS was significantly influenced by the Charlson Comorbidity Index (p < 0.001) and tumour grade (p = 0.025). Conclusions: PNETs are associated with excellent long-term survival following curative-intent resection. However, adverse pathological features are linked to an increased risk of recurrence and a poorer prognosis.
- 30 October 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (11) , 202
Open AccessOutcomes Following Surgery for Pancreatic Neuro-Endocrine Tumours: A Single-Centre Experience
Aims: The purpose of this study was to evaluate survival outcomes and recurrence patterns following curative-intent resection of pancreatic neuroendocrine tumours (PNETs) at a UK tertiary centre. The secondary aims included identifying prognostic clinicopathological factors that influenced survival. Methods: Patients undergoing curative-intent surgical resection for PNETs between August 2010 and March 2024 were retrospectively reviewed. The data collated included demographics, histopathology, recurrence, and survival outcomes. Results: Eighty-six patients were included, with a median age of 61.5 years (IQR: 50–71) and an equal sex distribution. Most tumours were solitary (88.4%) and located in the pancreatic tail (57%), with distal pancreatectomy performed in 75% of cases. The median tumour size was 25 mm (IQR: 13–40). Lymph node metastases were observed in 23.3% of patients, and R0 resection was achieved in 67%. Most of the PNETs resected were WHO grade 1 tumours (65.1%), followed by grade 2 tumours (26.7%). Postoperative morbidity occurred in 37.2% of cases, while the 30-day postoperative mortality rate was 1.5%. Recurrence was observed in 13.95% of patients, with a median time to recurrence of 36.3 months. The 5-year overall survival (OS) was 83.0%, with a median OS and disease-free survival (DFS) of 143.3 months and 147.0 months, respectively. Multivariable analysis revealed that poorer DFS was associated with larger tumours (p = 0.009), higher tumour grade (p = 0.006), male sex (p = 0.039), vascular invasion (p = 0.003), perineural invasion (p = 0.042) and lymph node metastases (p = 0.015). OS was significantly influenced by the Charlson Comorbidity Index (p < 0.001) and tumour grade (p = 0.025). Conclusions: PNETs are associated with excellent long-term survival following curative-intent resection. However, adverse pathological features are linked to an increased risk of recurrence and a poorer prognosis.
- Open Access
- 10 May 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (Supplement) , III48
P11 Satisfaction rates with telephone follow-up clinic appointments
Introduction: Since the onset of the COVID-19 pandemic, telephone follow-up (TFU) clinics have been an integral part of delivering healthcare. Advantages of telephone clinics include reducing costs and increasing efficiency. This quality improvement project (QIP) aims to evaluate patient satisfaction rates in a hot biliary telephone clinic. Methods: The Likert-scale is a 13-item questionnaire tool ranging from 1-5 (1=strongly disagree, 5=strongly agree) and was used to assess patient satisfaction with TFUs. Satisfactory cut-off point (score of 4) was analysed across all responses. Retrospective questionnaires were completed for 100 consented patients. Outcomes included overall satisfaction rate across gender and age groups. Results: Overall, 75% of patients were satisfied with TFUs. No statistical difference was found between male and female rates of satisfaction (67.6% and 79.4% respectively, p-value=0.19). Likewise, satisfaction rates did not differ by age (< 50 years: 72.2%, 50-59years: 88.9%, 60-69years: 71.4% and >70years: 72%, p-value: 0.52). Conclusion: Most patients were satisfied with TFUs. However, despite initial positive findings, there is still room to improve satisfaction. Prior to a re-evaluation, interventions such as offering patients the option of a telephone consult or a face-to-face appointment will be considered.
- 10 May 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (Supplement) , III48
Open AccessP11 Satisfaction rates with telephone follow-up clinic appointments
Introduction: Since the onset of the COVID-19 pandemic, telephone follow-up (TFU) clinics have been an integral part of delivering healthcare. Advantages of telephone clinics include reducing costs and increasing efficiency. This quality improvement project (QIP) aims to evaluate patient satisfaction rates in a hot biliary telephone clinic. Methods: The Likert-scale is a 13-item questionnaire tool ranging from 1-5 (1=strongly disagree, 5=strongly agree) and was used to assess patient satisfaction with TFUs. Satisfactory cut-off point (score of 4) was analysed across all responses. Retrospective questionnaires were completed for 100 consented patients. Outcomes included overall satisfaction rate across gender and age groups. Results: Overall, 75% of patients were satisfied with TFUs. No statistical difference was found between male and female rates of satisfaction (67.6% and 79.4% respectively, p-value=0.19). Likewise, satisfaction rates did not differ by age (< 50 years: 72.2%, 50-59years: 88.9%, 60-69years: 71.4% and >70years: 72%, p-value: 0.52). Conclusion: Most patients were satisfied with TFUs. However, despite initial positive findings, there is still room to improve satisfaction. Prior to a re-evaluation, interventions such as offering patients the option of a telephone consult or a face-to-face appointment will be considered.
- 1 September 2022
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 32 (9) , 962-968
Assessment of the Role of Omentopexy in Laparoscopic Sleeve Gastrectomy: A Tertiary Center Experience
Background: Laparoscopic sleeve gastrectomy is one of the most common bariatric procedures due its high success and low complication rates. However, acid reflux and food intolerance remain drawbacks of the procedure, with high frequency of postoperative gastroesophageal reflux disease (GERD) and eating disorders reported by previous studies. Omentopexy is not a standard technique in laparoscopic sleeve gastrectomy and showed promising results in preventing these sequelae. The present study aimed to evaluate whether omentopexy would decrease the incidence of postoperative GERD, food intolerance, and gastric volvulus without increasing additional complications rates in comparison with laparoscopic sleeve gastrectomy (LSG) without omentopexy. Patients and Methods: Our study included all the patients undergoing laparoscopic sleeve gastrectomy in our bariatric unit, who were divided into two groups. Group II had the added step of omentopexy. Comparison between both groups was done regarding incidence of acid reflux, food tolerance, and postoperative complications. Results: Omentopexy decreased the incidence of acid reflux, gastric kink, volvulus, and intrathoracic migration. Moreover, food tolerance significantly improved in patients, which in turn led to higher compliance with the postoperative dietary plan and better outcome with regard to weight loss. In addition, omentopexy showed lower incidence of postoperative leakage. Conclusion: Omentopexy is a valuable step in laparoscopic sleeve gastrectomy, which should be considered a standard step in all cases.
- 1 September 2022
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 32 (9) , 962-968
Assessment of the Role of Omentopexy in Laparoscopic Sleeve Gastrectomy: A Tertiary Center Experience
Background: Laparoscopic sleeve gastrectomy is one of the most common bariatric procedures due its high success and low complication rates. However, acid reflux and food intolerance remain drawbacks of the procedure, with high frequency of postoperative gastroesophageal reflux disease (GERD) and eating disorders reported by previous studies. Omentopexy is not a standard technique in laparoscopic sleeve gastrectomy and showed promising results in preventing these sequelae. The present study aimed to evaluate whether omentopexy would decrease the incidence of postoperative GERD, food intolerance, and gastric volvulus without increasing additional complications rates in comparison with laparoscopic sleeve gastrectomy (LSG) without omentopexy. Patients and Methods: Our study included all the patients undergoing laparoscopic sleeve gastrectomy in our bariatric unit, who were divided into two groups. Group II had the added step of omentopexy. Comparison between both groups was done regarding incidence of acid reflux, food tolerance, and postoperative complications. Results: Omentopexy decreased the incidence of acid reflux, gastric kink, volvulus, and intrathoracic migration. Moreover, food tolerance significantly improved in patients, which in turn led to higher compliance with the postoperative dietary plan and better outcome with regard to weight loss. In addition, omentopexy showed lower incidence of postoperative leakage. Conclusion: Omentopexy is a valuable step in laparoscopic sleeve gastrectomy, which should be considered a standard step in all cases.
- 7 January 2022
- Published by Wiley in World Journal of Surgery
- Vol. 46 (4) , 829-835
Assessment of Intraparenchymal Injection of 1% Patent Blue Dye in the Upper Outer Quadrant of the Breast to Identify Sentinel Lymph Node in Early Retro‐Areolar Breast Cancer in Women: A Tertiary Centre Experience in Egypt
Background: Sentinel lymph node biopsy is the gold standard for axillary assessment of patients with clinically node negative breast cancer. The current internationally accepted methods comprise of the usage of either a radioactive tracer, vital stains or the combination of both. However, in developing countries radioactive tracer is not widely used due to its high cost and limited availability. In addition, the classic retro‐areolar blue dye injection has a high failure rate.Objective: Our study aimed to assess the efficacy of patent blue dye injection in the upper outer quadrant of the breast after validation by concurrent usage of radioactive nanocolloid, in comparison with the classic retro‐areolar injection in identifying the sentinel node.Methods: A randomized control study involving 279 patients randomly divided into two groups. In group A lateral injection of 1% patent blue dye (validated by radioactive nanocolloid) was used, while subdermal patent blue dye injection in the retro‐areolar space was performed in group B.Results: The new technique showed the promising results with lower failure rate (3.4%) in comparison with the classic retro‐areolar patent blue injection (13.7%).Conclusions: The lateral injection technique can be result in comparable results to the combination technique with the added benefit of being widely available and a cheaper option especially in developing countries.
- 7 January 2022
- Published by Wiley in World Journal of Surgery
- Vol. 46 (4) , 829-835
Assessment of Intraparenchymal Injection of 1% Patent Blue Dye in the Upper Outer Quadrant of the Breast to Identify Sentinel Lymph Node in Early Retro‐Areolar Breast Cancer in Women: A Tertiary Centre Experience in Egypt
Background: Sentinel lymph node biopsy is the gold standard for axillary assessment of patients with clinically node negative breast cancer. The current internationally accepted methods comprise of the usage of either a radioactive tracer, vital stains or the combination of both. However, in developing countries radioactive tracer is not widely used due to its high cost and limited availability. In addition, the classic retro‐areolar blue dye injection has a high failure rate.Objective: Our study aimed to assess the efficacy of patent blue dye injection in the upper outer quadrant of the breast after validation by concurrent usage of radioactive nanocolloid, in comparison with the classic retro‐areolar injection in identifying the sentinel node.Methods: A randomized control study involving 279 patients randomly divided into two groups. In group A lateral injection of 1% patent blue dye (validated by radioactive nanocolloid) was used, while subdermal patent blue dye injection in the retro‐areolar space was performed in group B.Results: The new technique showed the promising results with lower failure rate (3.4%) in comparison with the classic retro‐areolar patent blue injection (13.7%).Conclusions: The lateral injection technique can be result in comparable results to the combination technique with the added benefit of being widely available and a cheaper option especially in developing countries.
- Open Access
- 1 September 2021
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 15 (1) , 128-136
Effect of the COVID‐19 Pandemic on the Management of Acute Cholecystitis and Assessment of the Crisis Approach: A Multicenter Experience in Egypt
Introduction The covid-19 pandemic has had a drastic impact on all medical services. Acute cholecystitis is a serious condition that accounts for a considerable percentage of general surgical acute admissions. Therefore, the Royal College of Surgeons' Commissioning guidance' recommended urgent admission to secondary care and early cholecystectomy. During the first wave of hospital admissions associated with COVID-19, most guidelines recommended conservative treatment in order to limit the admission rates and free up spaces for COVID-19-infected patients. However, reviews of this approach have not been widely done to assess the results and, in turn, planning our future management approach when future pressures on in-patient admissions are inevitable. Methods Our study included all acute cholecystitis patients who needed surgical intervention in one Centre in the UK over three distinct periods (pre-COVID-19, during the first lockdown, and lockdown ease). Comparison between these groups were done regarding intraoperative and postoperative results. Results The conservative management led to a high rate of readmission. Moreover, delayed cholecystectomy was associated with increased operative difficulties such as extensive adhesions, intraoperative blood loss, and/or complicated gall bladder pathologies such as perforated or gangrenous gall bladder (29.9%, 16.7%, and 24.8%, respectively). The resulting postoperative complications of surgical and nonsurgical resulted in a longer hospital stay (13.5 d). Conclusion The crisis approach for acute cholecystitis management failed to deliver the hoped outcome. Instead, it backfired and did the exact opposite, leading to longer hospital stays and extra burden to the patient and the healthcare system.
- 1 September 2021
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 15 (1) , 128-136
Open AccessEffect of the COVID‐19 Pandemic on the Management of Acute Cholecystitis and Assessment of the Crisis Approach: A Multicenter Experience in Egypt
Introduction The covid-19 pandemic has had a drastic impact on all medical services. Acute cholecystitis is a serious condition that accounts for a considerable percentage of general surgical acute admissions. Therefore, the Royal College of Surgeons' Commissioning guidance' recommended urgent admission to secondary care and early cholecystectomy. During the first wave of hospital admissions associated with COVID-19, most guidelines recommended conservative treatment in order to limit the admission rates and free up spaces for COVID-19-infected patients. However, reviews of this approach have not been widely done to assess the results and, in turn, planning our future management approach when future pressures on in-patient admissions are inevitable. Methods Our study included all acute cholecystitis patients who needed surgical intervention in one Centre in the UK over three distinct periods (pre-COVID-19, during the first lockdown, and lockdown ease). Comparison between these groups were done regarding intraoperative and postoperative results. Results The conservative management led to a high rate of readmission. Moreover, delayed cholecystectomy was associated with increased operative difficulties such as extensive adhesions, intraoperative blood loss, and/or complicated gall bladder pathologies such as perforated or gangrenous gall bladder (29.9%, 16.7%, and 24.8%, respectively). The resulting postoperative complications of surgical and nonsurgical resulted in a longer hospital stay (13.5 d). Conclusion The crisis approach for acute cholecystitis management failed to deliver the hoped outcome. Instead, it backfired and did the exact opposite, leading to longer hospital stays and extra burden to the patient and the healthcare system.